Search Contract Opportunities

COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5 and Influenza A/H7 Extraction Reagents

ID: N3239825Q3163 • Type: Special Notice

Description

The United States Department of the Naval Medical Research Command (NMRC) intends to award a sole source contract to, Roche Diagnostics Corporation, Indianapolis, Indiana. This requirement is for brand name equipment. This notice is not a request for competitive proposals however If interested, please submit a capability statement for Government consideration.

NMRC's Naval Infectious Diseases Diagnostic Laboratory is in need for a drop shipment of Roche supplies needed for COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5 and Influenza A/H7 extraction reagents. This requirement is for the purchase of reagents for 1,000 extraction reactions for the assays mentioned every two months for six complete shipments, for a total of 6,000 reactions.

Specific items include:

(1) MagNA Pure 96 Processing Cartridge (Cat. 06241603001)/QTY: 18;

(2) MagNA Pure 96 Output Plate (Cat. 0624161/QTY: 6;

(3) MagNA Pure Filter Tips (1000 ul) (Cat. 06241620001)/QTY: 6;

(4) MagNA Pure External Lysis Buffer (Cat. 06374913001)/QTY: 6;

(5) MagNA Pure External Lysis Buffer (Cat. 06374913001)/QTY: 48;

(6) MagNA Pure 96 DNA and Viral NA SV Kit (Cat. 06543588001)/QTY: 12; and

(7) MagNA Pure 96 System Fluid (External) (Cat. 06640729001)/QTY: 12.

Please note that this requirement includes numerous shipments and the proposed shipping schedule is included below. There will be six separate bi-monthly shipments. Proposed ship schedule: Jun-2025, Aug-2025, Oct-2025, Dec-2025, Feb-2026, Apr-2026.

The NAICS code for this action is 325413. This requirement will be procured under the guidelines of FAR Part 12 Commercial Items. NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems for Award Management (SAM). No award can be made unless the vendor is registered in Systems for Award Management. For additional information and to register in SAM, please access the following website: https://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this Acquisition Office, all offers must have a Unique Entity Identification Number (UEI). A Sam.gov number may be acquired free of charge by contacting Sam.gov online at www.sam.gov or by phone at (866) 606-8220

Background
The United States Department of the Naval Medical Research Command (NMRC) intends to award a sole source contract to Roche Diagnostics Corporation, located in Indianapolis, Indiana. This contract is aimed at fulfilling the needs of NMRC's Naval Infectious Diseases Diagnostic Laboratory, which is responsible for conducting critical research and diagnostics related to infectious diseases. The goal of this contract is to procure essential supplies for COVID-19 and various influenza assays, ensuring that the laboratory can continue its vital work in public health.

Work Details
The contract involves a drop shipment of Roche supplies necessary for COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5, and Influenza A/H7 extraction reagents. The requirement includes reagents for 1,000 extraction reactions every two months over six shipments, totaling 6,000 reactions. Specific items to be delivered include:

1. MagNA Pure 96 Processing Cartridge (Cat. 06241603001) - Quantity: 18
2. MagNA Pure 96 Output Plate (Cat. 0624161) - Quantity: 6
3. MagNA Pure Filter Tips (1000 ul) (Cat. 06241620001) - Quantity: 6
4. MagNA Pure External Lysis Buffer (Cat. 06374913001) - Quantity: 54 (6 + 48)
5. MagNA Pure 96 DNA and Viral NA SV Kit (Cat. 06543588001) - Quantity: 12
6. MagNA Pure 96 System Fluid (External) (Cat. 06640729001) - Quantity: 12.

The proposed shipping schedule includes six separate bi-monthly shipments planned for June 2025, August 2025, October 2025, December 2025, February 2026, and April 2026.

Period of Performance
The period of performance includes multiple shipments scheduled from June 2025 through April 2026.

Place of Performance
The products will be delivered to the Naval Medical Research Command located in Silver Spring, MD.

Overview

Response Deadline
April 29, 2025, 5:00 p.m. EDT Due in 7 Days
Posted
April 14, 2025, 3:21 p.m. EDT
Set Aside
None
Place of Performance
MD 20910 United States
Source
SAM

Current SBA Size Standard
1250 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Sole Source
On 4/14/25 Bureau of Medicine and Surgery issued Special Notice N3239825Q3163 for COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5 and Influenza A/H7 Extraction Reagents due 4/29/25.
Primary Contact
Name
SHAMAI CARTER   Profile
Phone
None

Secondary Contact

Name
DEBORAH SHARPE   Profile
Phone
None

Documents

Posted documents for Special Notice N3239825Q3163

Question & Answer

Incumbent or Similar Awards

Contracts Similar to Special Notice N3239825Q3163

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice N3239825Q3163

Similar Active Opportunities

Open contract opportunities similar to Special Notice N3239825Q3163

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEPT OF THE NAVY > NAVSUP > NAVSUP OTHER HCA > BUMED > NAVY MEDICINE WEST
FPDS Organization Code
1700-N32398
Source Organization Code
500018734
Last Updated
April 14, 2025
Last Updated By
shamai.m.carter.civ@health.mil
Archive Date
May 14, 2025